"14th Five-Year" Chinese Medicine Development Plan released!

On March 29, the General Office of the State Council issued a notice on the “14th Five-Year Plan” for the development of traditional Chinese medicine.

"14th Five-Year Plan" Chinese Medicine Development Plan Released

On March 29, the General Office of the State Council issued a notice on the "14th Five-Year Plan" for the development of traditional Chinese medicine

"14th Five-Year" development goals:

By 2025, the health service capacity of traditional Chinese medicine will be significantly enhanced, the high-quality development policy and system of traditional Chinese medicine will be further improved, the revitalization and development of traditional Chinese medicine will achieve positive results, and the unique advantages in the construction of a healthy China will be fully utilized

——The traditional Chinese medicine service system was further improved

——The construction of talents with characteristics of traditional Chinese medicine will be accelerated

——The ability to inherit and innovate traditional Chinese medicine has been continuously enhanced

——The high-quality development of the traditional Chinese medicine industry and the health service industry has achieved positive results

- Vigorously carry forward the traditional Chinese medicine culture

—— Actively promote the opening and development of traditional Chinese medicine

——The management level of traditional Chinese medicine has been further improved

In promoting the high-quality development of the traditional Chinese medicine industry:

1.

2.

3.

4.

solicit opinions! Clinically urgently needed drugs can be temporarily imported, and these three types of drugs are eligible

On March 29, the National Health and Medical Commission and the State Food and Drug Administration issued an announcement on the public consultation on the "Work Plan for the Temporary Import of Clinically Urgently Needed Drugs" and the "Work Plan for the Temporary Import of Clobazam".

According to the Work Plan for the Temporary Import of Drugs in Urgently Needed Clinical Medicine (Draft for Comment), the plan is applicable to a small amount of drugs that have been marketed in overseas markets that have not been registered in China, have not been produced by enterprises, or cannot resume production in a short period of time

(1) Medicines for the treatment of rare diseases;

(2) Medicines for the prevention and treatment of serious life-threatening diseases for which there is no effective means of treatment or prevention;

(3) Medicines for the prevention and treatment of serious life-threatening diseases with obvious clinical advantages
.

Temporary importation of clobazam, prescribing physicians need to meet these requirements

In order to meet the urgent need for clinical use of clobazam, a work plan for the temporary import of clobazam was formulated in accordance with the relevant provisions of the "Work Plan for Temporary Import of Drugs in Urgent Clinical Needs"
.
In the Work Plan for Temporary Import of Clobazam (Draft for Comment), relevant requirements for the qualifications and management of prescribing physicians are put forward:

(1) Engaged in the diagnosis and treatment of epilepsy or childhood epilepsy for more than 10 years, as a deputy chief physician or chief physician;

(2) Possess the right to prescribe narcotic drugs and psychotropic drugs;

(3) Have clinical experience in using benzodiazepines to treat epilepsy;

(4) Be able to strictly grasp the indications of clobazam (limited to epilepsy);

(5) Familiar with the usage and dosage of clobazam, evaluation of therapeutic effect, monitoring and treatment of adverse reactions;

(6) In accordance with the current requirements for the use of benzodiazepines in their respective hospitals, and each prescription should not exceed a maximum of 1 month's consumption
.